申请人:——
公开号:US20030073688A1
公开(公告)日:2003-04-17
The present invention relates to a class of compounds represented by the formula (I)
1
or a pharmaceutical acceptable salt, prodrug or ester thereof, pharmaceutical compositions comprising compounds of the formula (I), and methods of selectively inhibiting or antagonizing &agr;
v
&bgr;
3
integrin.
本发明涉及一类化合物,其公式表示为(I)1,或其药学上可接受的盐、前药或酯,包括公式(I)的化合物的药物组合物,并且涉及选择性抑制或拮抗αvβ3整合素的方法。